TLR7 and neoplasm: Nevertheless, given that TLR7 is expressed in myeloid cells that exert early influence on the anti-tumor immune response and affect various immune cell populations, it is expected that DSP-0509 would prove effective not only in conjunction with anti-PD-1 antibodies but also in combination with other immunotherapeutic agents.